Ryan Nelson
Editor-in-Chief, Medtech Insight, HBW Insight
Ryan has been covering the medical device and consumer health, wellness and beauty sectors since 2004, first as a reporter for Gray Sheet, where he covered beats including Capitol Hill, international and emerging technology, and then as managing editor of Rose Sheet. In his current role, he oversees and heads up strategy for their successor publications Medtech Insight and HBW Insight. He also manages and contributes regularly to HBW Insight’s Beauty channel with a focus on regulatory, policy and legal issues and has moderated related panels at industry events. Ryan has a growing role in developing podcasts, new features, “deep dive” article series, and infographics across teams and publications. Off the job, he enjoys spending time with his wife Katie, son Finn and daughter Maggie in Alexandria, VA, a DC suburb.
Latest From Ryan Nelson
AI News: Lauder Expands Microsoft Partnership; Prose Beauty; Supply Chain Software; More
The Estee Lauder Companies’ expanding use of artificial intelligence includes an internal-facing generative AI chatbot to help users “efficiently navigate and further leverage ELC's proprietary and extensive database of product and claim data.” Meanwhile, Prose Beauty is leveraging AI to market personalized skin and hair products at scale, and Vagaro to provide salons and spas with “instantly crafting polished communications, such as service and policy descriptions, effective marketing messaging, and more.”
Hot Or Bot? ‘Miss AI’ Pageant Will Judge Human Influencers’ New Competition
Emily Pellegrini and Aitana Lopez, both AI creations themselves, are listed as judges in the World AI Creator Awards’ Miss AI pageant for AI-generated models. Unilever has taken an early stand against using AI in place of real women in its advertising, but human beauty influencers must be on alert.
Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat
Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.
L’Oreal Joins J&J And Major Retailers Defending Benzene Class Actions In Federal Courts
Benzoyl peroxide-based acne drug products and their alleged proclivity to become contaminated with carcinogenic benzene are at the center of putative class actions filing against L’Oreal in federal courts around the US.
National Advertising Division Shuts Down Skincarebrandsreviews Website
NourishMax agreed to discontinue “top pick” claims for its Diamond Infused Eye Cream and fold up its website that looked suspiciously to NAD like advertising in the guise of independent, honest reviews.
Cue The Class Actions! Plaintiffs React To Valisure’s Benzene Findings In Acne Drug Products
J&J, Target and Walgreens face class action complaints in California federal courts for economic harms caused by their sale of benzoyl peroxide-containing acne treatments, following Valisure’s 5 March citizen petition to the US FDA on findings of high levels of benzene in such products.